CD274 and cancer: PD-L1 is an immune checkpoint protein expressed on various cells, including cancer cells, that binds to PD-1 receptors on T cells to suppress their activity, allowing cancer cells to evade immune detection (Yamaguchi et al. 2022, Yi et al. 2022).